Group B Streptococcus Carriage in Pregnancy: Burden of Early-onset Neonatal Disease and Estimation of the Cost of Universal Antenatal Screening in a Hospital of the Eastern Region of Saudi Arabia

Introduction: Group B streptococcus (GBS) is recognized as a significant cause of neonatal infections worldwide. The study investigated the burden of early-onset neonatal disease and assessed the cost of routine GBS screening in a hospital of the eastern region of Saudi Arabia. Materials and Method...

Full description

Bibliographic Details
Main Authors: Arif M. AL-HAMAD, Mohammed M. ALJELDAH, Mahmoud ALSHEIKH, Ruqayah GAZEWI, Maha AL-IBRAHIM
Format: Article
Language:Turkish
Published: Galenos Yayinevi 2023-12-01
Series:Mediterranean Journal of Infection, Microbes and Antimicrobials
Subjects:
Online Access:https://mjima.org/text.php?&id=397
_version_ 1797338761625862144
author Arif M. AL-HAMAD
Mohammed M. ALJELDAH
Mahmoud ALSHEIKH
Ruqayah GAZEWI
Maha AL-IBRAHIM
author_facet Arif M. AL-HAMAD
Mohammed M. ALJELDAH
Mahmoud ALSHEIKH
Ruqayah GAZEWI
Maha AL-IBRAHIM
author_sort Arif M. AL-HAMAD
collection DOAJ
description Introduction: Group B streptococcus (GBS) is recognized as a significant cause of neonatal infections worldwide. The study investigated the burden of early-onset neonatal disease and assessed the cost of routine GBS screening in a hospital of the eastern region of Saudi Arabia. Materials and Methods: Pregnancy-related information and laboratory-related data for pregnant women for the period of 2016-2017 were used to determine the colonization rate of GBS. The efficiency of intrapartum antibiotic prophylaxis (IAP) was examined among pregnant women carrying GBS and delivered at the hospital. The cost of GBS routine screening was estimated based on the cost of rectovaginal swab enrichment in BBLTM LIM broth and confirmation by polymerase chain reaction. The burden of early-onset disease and rates of resistance to antibiotics among vaginal and invasive neonatal isolates were investigated for seven years. Results: Screening of 2,476 samples from 1,162 pregnant women in two years showed a GBS colonization rate of 23% (270/1162). Of the 270 GBS-positive women, only 98 (37%) delivered at the hospital, of whom 42% received IAP. Cesarean delivery was associated with significantly higher rates of IAP administration (odds ratio 5.2; p value 0.001). The annual incidence of early-onset disease increased from a baseline level of 0.5 in 2012 to 3.9 per 1,000 births in 2018. These included 23 cases of invasive infections with three fatal cases caused by meningitis or sepsis (3/23, 13%). Group B streptococcus isolates remained uniformly sensitive to penicillin and vancomycin but exhibited resistance to clindamycin in 35.2%. The annual estimated costs of routine screening would be $110,880 ($41 per delivery) and $161,280 ($60 per delivery) for the BD MAX™ system and GeneXpert® System, respectively. Conclusion: While the incidence of early-onset GBS disease was increasing, improved compliance with the IAP is needed to inform the cost-effectiveness of routine GBS screening.
first_indexed 2024-03-08T09:35:58Z
format Article
id doaj.art-8c4d888e369d44f291b8ebb51137885f
institution Directory Open Access Journal
issn 2147-673X
language Turkish
last_indexed 2024-03-08T09:35:58Z
publishDate 2023-12-01
publisher Galenos Yayinevi
record_format Article
series Mediterranean Journal of Infection, Microbes and Antimicrobials
spelling doaj.art-8c4d888e369d44f291b8ebb51137885f2024-01-30T08:48:29ZturGalenos YayineviMediterranean Journal of Infection, Microbes and Antimicrobials2147-673X2023-12-0112110.4274/mjima.galenos.2023.2023.31Group B Streptococcus Carriage in Pregnancy: Burden of Early-onset Neonatal Disease and Estimation of the Cost of Universal Antenatal Screening in a Hospital of the Eastern Region of Saudi ArabiaArif M. AL-HAMAD0https://orcid.org/0000-0003-0148-3131Mohammed M. ALJELDAH1https://orcid.org/0000-0001-5335-2809Mahmoud ALSHEIKH2Ruqayah GAZEWI3Maha AL-IBRAHIM4Qatif Central Hospital, Clinic of Clinical Microbiology, Al-Qatif, Saudi ArabiaUniversity of Hafr Al Batin, College of Applied Medical Sciences, Department of Clinical Laboratory Sciences, Hafr Al Batin, Saudi ArabiaArmed Forces Hospital, Clinic of Physical Medicine and Rehabilitation, Al-Taif, Saudi ArabiaQatif Central Hospital, Clinic of Clinical Microbiology, Al-Qatif, Saudi ArabiaQatif Central Hospital, Clinic of Clinical Microbiology, Al-Qatif, Saudi ArabiaIntroduction: Group B streptococcus (GBS) is recognized as a significant cause of neonatal infections worldwide. The study investigated the burden of early-onset neonatal disease and assessed the cost of routine GBS screening in a hospital of the eastern region of Saudi Arabia. Materials and Methods: Pregnancy-related information and laboratory-related data for pregnant women for the period of 2016-2017 were used to determine the colonization rate of GBS. The efficiency of intrapartum antibiotic prophylaxis (IAP) was examined among pregnant women carrying GBS and delivered at the hospital. The cost of GBS routine screening was estimated based on the cost of rectovaginal swab enrichment in BBLTM LIM broth and confirmation by polymerase chain reaction. The burden of early-onset disease and rates of resistance to antibiotics among vaginal and invasive neonatal isolates were investigated for seven years. Results: Screening of 2,476 samples from 1,162 pregnant women in two years showed a GBS colonization rate of 23% (270/1162). Of the 270 GBS-positive women, only 98 (37%) delivered at the hospital, of whom 42% received IAP. Cesarean delivery was associated with significantly higher rates of IAP administration (odds ratio 5.2; p value 0.001). The annual incidence of early-onset disease increased from a baseline level of 0.5 in 2012 to 3.9 per 1,000 births in 2018. These included 23 cases of invasive infections with three fatal cases caused by meningitis or sepsis (3/23, 13%). Group B streptococcus isolates remained uniformly sensitive to penicillin and vancomycin but exhibited resistance to clindamycin in 35.2%. The annual estimated costs of routine screening would be $110,880 ($41 per delivery) and $161,280 ($60 per delivery) for the BD MAX™ system and GeneXpert® System, respectively. Conclusion: While the incidence of early-onset GBS disease was increasing, improved compliance with the IAP is needed to inform the cost-effectiveness of routine GBS screening.https://mjima.org/text.php?&id=397s. agalactiaeneonatal sepsisclindamycin resistanceearly onset
spellingShingle Arif M. AL-HAMAD
Mohammed M. ALJELDAH
Mahmoud ALSHEIKH
Ruqayah GAZEWI
Maha AL-IBRAHIM
Group B Streptococcus Carriage in Pregnancy: Burden of Early-onset Neonatal Disease and Estimation of the Cost of Universal Antenatal Screening in a Hospital of the Eastern Region of Saudi Arabia
Mediterranean Journal of Infection, Microbes and Antimicrobials
s. agalactiae
neonatal sepsis
clindamycin resistance
early onset
title Group B Streptococcus Carriage in Pregnancy: Burden of Early-onset Neonatal Disease and Estimation of the Cost of Universal Antenatal Screening in a Hospital of the Eastern Region of Saudi Arabia
title_full Group B Streptococcus Carriage in Pregnancy: Burden of Early-onset Neonatal Disease and Estimation of the Cost of Universal Antenatal Screening in a Hospital of the Eastern Region of Saudi Arabia
title_fullStr Group B Streptococcus Carriage in Pregnancy: Burden of Early-onset Neonatal Disease and Estimation of the Cost of Universal Antenatal Screening in a Hospital of the Eastern Region of Saudi Arabia
title_full_unstemmed Group B Streptococcus Carriage in Pregnancy: Burden of Early-onset Neonatal Disease and Estimation of the Cost of Universal Antenatal Screening in a Hospital of the Eastern Region of Saudi Arabia
title_short Group B Streptococcus Carriage in Pregnancy: Burden of Early-onset Neonatal Disease and Estimation of the Cost of Universal Antenatal Screening in a Hospital of the Eastern Region of Saudi Arabia
title_sort group b streptococcus carriage in pregnancy burden of early onset neonatal disease and estimation of the cost of universal antenatal screening in a hospital of the eastern region of saudi arabia
topic s. agalactiae
neonatal sepsis
clindamycin resistance
early onset
url https://mjima.org/text.php?&id=397
work_keys_str_mv AT arifmalhamad groupbstreptococcuscarriageinpregnancyburdenofearlyonsetneonataldiseaseandestimationofthecostofuniversalantenatalscreeninginahospitaloftheeasternregionofsaudiarabia
AT mohammedmaljeldah groupbstreptococcuscarriageinpregnancyburdenofearlyonsetneonataldiseaseandestimationofthecostofuniversalantenatalscreeninginahospitaloftheeasternregionofsaudiarabia
AT mahmoudalsheikh groupbstreptococcuscarriageinpregnancyburdenofearlyonsetneonataldiseaseandestimationofthecostofuniversalantenatalscreeninginahospitaloftheeasternregionofsaudiarabia
AT ruqayahgazewi groupbstreptococcuscarriageinpregnancyburdenofearlyonsetneonataldiseaseandestimationofthecostofuniversalantenatalscreeninginahospitaloftheeasternregionofsaudiarabia
AT mahaalibrahim groupbstreptococcuscarriageinpregnancyburdenofearlyonsetneonataldiseaseandestimationofthecostofuniversalantenatalscreeninginahospitaloftheeasternregionofsaudiarabia